Jul 28, 2025 08:00AM
Jul 28, 2025 08:00AM
Mar 21, 2025 06:00AM
Mar 5, 2025 07:02AM
Mar 5, 2025 07:00AM
May 1, 2024 07:00AM
Mar 21, 2024 07:01AM Chimerix (CMRX) Appoints Marc D. Kozin to its Board
Mar 21, 2024 07:00AM
Nov 16, 2023 07:03AM
Nov 16, 2023 07:00AM
Jun 27, 2023 04:05PM
Jun 27, 2023 04:05PM
Aug 8, 2022 04:01PM
Aug 1, 2022 08:10AM Chimerix (CMRX) and Emergent BioSolutions (EBS) Disclose Expiration of HSR Waiting Period for Acquisition of Rights to Brincidofovir
Jul 25, 2022 09:12AM
May 16, 2022 09:25AM
May 16, 2022 07:00AM
May 16, 2022 06:33AM
May 16, 2022 06:32AM
May 16, 2022 06:32AM
May 16, 2022 06:30AM Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
May 9, 2022 07:00AM
Mar 1, 2022 07:00AM
Feb 22, 2022 07:00AM
Jan 18, 2022 04:02PM
Jan 18, 2022 04:01PM
Nov 19, 2021 07:02AM
Nov 19, 2021 07:00AM Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting
Nov 4, 2021 07:05AM
Nov 4, 2021 07:04AM
Nov 4, 2021 07:00AM
Oct 28, 2021 07:00AM
Aug 5, 2021 07:00AM
Aug 3, 2021 07:00AM
Jul 29, 2021 07:00AM Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021
May 6, 2021 07:00AM
Apr 29, 2021 07:00AM
Apr 26, 2021 07:08AM
Apr 26, 2021 07:00AM
Feb 25, 2021 07:00AM
Feb 18, 2021 07:00AM
Jan 25, 2021 05:44PM Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 21, 2021 05:57AM
Jan 20, 2021 08:02PM
Jan 19, 2021 04:19PM
Jan 19, 2021 04:18PM
Jan 8, 2021 09:30AM
Jan 8, 2021 06:16AM
Jan 8, 2021 06:00AM Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
Aug 8, 2019 08:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All